A cohort event monitoring study to characterise use of eplontersen in patients with prior liver transplant and pre-existing severe hepatic impairment and to assess long-term safety among all new users of eplontersen (sTTRing) First published 05/01/2026 Last updated 05/01/2026 EU PAS number:EUPAS1000000890 Study Planned